A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults
Status: | Recruiting |
---|---|
Conditions: | Constipation |
Therapuetic Areas: | Gastroenterology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/30/2013 |
Start Date: | August 2012 |
Contact: | John McGowan, MPH |
Email: | jmcgowan@braintreelabs.com |
A pilot study to evaluate the safety and efficacy of multiple BLI801 doses in constipated
adults.
Inclusion Criteria:
Male or female subjects at least 18 years of age
Constipated, defined by ROME definition:
Otherwise in good health, as determined by physical exam and medical history
Exclusion Criteria:
Subjects with known or suspected ileus, gastrointestinal obstruction, gastric retention,
bowel perforation, toxic colitis, toxic megacolon
Subjects taking laxatives or prokinetic agents that refuse to discontinue these
treatments
Subjects who are allergic to any BLI801 component
Subjects currently taking narcotic analgesics or other medications known to cause
constipation
Subjects who, in the opinion of the Investigator, should not be included in the study for
any reason, including inability to follow study procedures
Subjects who have participated in an investigational clinical, surgical, drug, or device
study within the past 30 days
Subjects with an active history of drug or alcohol abuse
We found this trial at
4
sites
Click here to add this to my saved trials
Anaheim Clinical Trials, LLC Anaheim Clinical Trials (ACT) is a research center of excellence for...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials